Stephen Hansen Senior Writer An increase in regulatory approvals and new breakthrough therapies has money managers buying into the concept that biotech has entered a new product cycle that provides a strong fundamental basis for...

Scolr Pharma Inc. (OTCBB:SCLR), Bothell, Wash. Business: Drug delivery Date completed: 6/16/11 Type: Private placement of convertible debentures and warrants Raised: $1 million Shares outstanding prior: 49.8 million Note: The senior secured debentures bear 8%...